Zydus Company Profile

✉ Email this page to a colleague

ZYDUS has three hundred and sixty-six approved drugs.

There is one US patent protecting ZYDUS drugs. There are twenty-six tentative approvals on ZYDUS drugs.

There are four patent family members on ZYDUS drugs in four countries and nine hundred and seven supplementary protection certificates in eighteen countries.

International Patents:	4
US Patents:	1
Tradenames:	296
Ingredients:	287
NDAs:	366
Patent Litigation for Zydus:	See patent lawsuits for Zydus

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms	NYSTATIN	nystatin	POWDER;TOPICAL	208581-001	Jun 8, 2017	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms Usa Inc	RISPERIDONE	risperidone	TABLET;ORAL	078040-003	Oct 16, 2008	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms Usa Inc	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; losartan potassium	TABLET;ORAL	078385-001	Oct 6, 2010	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	RISEDRONATE SODIUM	risedronate sodium	TABLET, DELAYED RELEASE;ORAL	203822-001	Sep 11, 2018		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	OLANZAPINE	olanzapine	TABLET;ORAL	090459-001	Jul 16, 2018	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015128877	⤷ Try a Trial
India	651MU2014	⤷ Try a Trial
South Africa	201606075	⤷ Try a Trial
Philippines	12016501686	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1667986	92172	Luxembourg	⤷ Try a Trial	PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
2487163	2016C/066	Belgium	⤷ Try a Trial	PRODUCT NAME: COBICISTAT ET ATAZANAVIR; AUTHORISATION NUMBER AND DATE: EU/1/15/1025 20150715
3150586	PA2020508,C3150586	Lithuania	⤷ Try a Trial	PRODUCT NAME: KOBICISTATAS ARBA FARMACINIU POZIURIU PRIIMTINA JO DRUSKA ARBA SOLVATAS, DARUNAVIRAS ARBA FARMACINIU POZIURIU PRIIMTINA JO DRUSKA ARBA SOLVATAS, YPAC DARUNAVIRO ETANOLATAS, IR EMTRICITABINAS, ARBA FARMACINIU POZIURIU PRIIMTINA JO DRUSKA ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/17/1225 20170921
0273658	C300171	Netherlands	⤷ Try a Trial	PRODUCT NAME: DULOXETINE EN FARMACEUTISCH AANVAARDBARE ZUURADDITIEZOUTEN DAARVAN, EN IN HET BIJZONDER DULOXETINE HYDROCHLORIDE; NATL REGISTRATION NO/DATE: EU/1/04/280/001-006 20040811
1452524	C01452524/01	Switzerland	⤷ Try a Trial	PRODUCT NAME: BRIVARACETAM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65830 06.10.2016
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.